What to watch for as Novartis heads to the FDA with a novel cancer therapy
(By Damian Garde and Adam Feurerstein for STAT) The FDA has weighed in on Novartis’ pioneering personalized cancer therapy, which
Read More
Medical Technology
Uberization of Senior Services
With on-demand services designed primarily for the young and overworked, the “uberization” of senior services holds a real promise for
Read MoreTelemedicine Is Wide-Reaching But Doesn’t Always Replace Doctor’s Touch
(By Elaine Korry for California Healthline) Two years ago, Kimberly Griffiths’ week-old daughter, Avery, suddenly became very ill. “She was
Read MorePersonalized cancer vaccines vanquish melanoma in small but encouraging study
(By Sharon Begley for STAT) A small pilot study raises hopes that personalized cancer vaccines might prove safer and more effective than
Read MoreSecond Sight (EYES) Announces Expansion Of Medicare Coverage For Argus II Retinal Prosthesis System To 11 Additional States And The District Of Columbia
Argus II Can Now Be Covered in Seven of 12 Medicare Administrative Contractor Jurisdictions, representing a total of 28 states,
Read More23andMe: Direct to Consumer Genetic Test without Prescription
23andMe, the first company to win approval from the FDA to sell “direct to consumer” genetic test for five diseases
Read MoreComputer Game Shown to Improve Memory
British neuroscientists have developed a computer game shown to improve the memory of patients in the very earliest stages of
Read MoreDrug Companies Turning to Artificial Intelligence
GlaxoSmithKline, one of the world’s leading drug companies, is turning to artificial intelligence to help streamline the drug discovery process.
Read MoreRoche acquires digital health firm mySugr
(By Jessica Kim Cohen for Becker’s Hospital Review) Roche, a Basel, Switzerland-based pharmaceutical company, signed an agreement to acquire all shares of
Read MoreRoutine DNA Sequencing May Be Helpful And Not As Scary As Feared
(By Rob Stein for NPR) Advances in technology have made it much easier, faster and less expensive to do whole genome
Read More